The KRW 600 billion antithrombotic industry is showing high interests in rapid growth of new products
Antithrombotic products, which have been 3 years since their launch, are energizing its depressed market through their rapid growth.
Particularly, Cilostan (Korea United Pharm) and Brilinta (AstraZeneca) have become dark horses as increasing almost double in prescription expenses compared to the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
